Elimination of methadone benefits in the Oregon Health Plan and its effects on patients.

Elimination of methadone benefits in the Oregon Health Plan and its effects on patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Elimination of methadone benefits in the Oregon Health Plan and its effects on patients. Abstract Text:

Bret E Fuller,Traci R Rieckmann,Dennis J McCarty,Roz Ringor-Carty,Sandy Kennard,

OBJECTIVES: This prospective study assessed the impacts of a policy change to Oregon's Medicaid program (Oregon Health Plan; OHP) that eliminated methadone benefits for 60 percent of active methadone patients. Recipients of OHP Standard (expanded Medicaid benefits, which were discontinued after the policy change) self-selected into two groups: those who paid for methadone after the policy change and those who terminated treatment. OHP Plus beneficiaries (traditional Medicaid) did not lose benefits. METHODS: A total of 149 patients participated in the study, and interviews were conducted at baseline (time of policy change) and one, three, and 12 months after the policy change. Patients were assessed with the Addiction Severity Index (ASI), Timeline Follow Back assessment, and chart review. RESULTS: Patients who left treatment because they were unable to pay for methadone services showed significant elevations in ASI composite scores for drug and legal problems at baseline and at two and three months after the policy change. The patients who attempted to self-pay experienced significantly more employment problems than the other two groups. The OHP Standard recipients who paid for their methadone treatment over the year were more likely to have additional resources to pay for methadone, be employed, and have stable housing. CONCLUSIONS: The elimination of methadone treatment benefits in the OHP had substantial negative impacts for patients with the greatest indicators of need.

Elimination of methadone benefits in the Oregon Health Plan and its effects on patients. Publishing Authors By Initials

BE Fuller,TR Rieckmann,DJ McCarty,R Ringor-Carty,S Kennard,

For similar geographic locations: americas: north america: united states research abstracts see: geographic locations: americas: north america: united states research

PUBMED ID PMID:

MEDLINE DATE:

Elimination of methadone benefits in the Oregon Health Plan and its effects on patients. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Psychiatric services (Washington, D.C.)

VOLUME: 57

Page Numbers: 686-91

Journal Abbreviation:

ISSN: 1075-2730

DAY: 3

MONTH: May

YEAR: 2006

Elimination of methadone benefits in the Oregon Health Plan and its effects on patients. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9502838

Elimination of methadone benefits in the Oregon Health Plan and its effects on patients. Keywords Mesh Terms:

KEYWORDS: United States

MESH TERMS: psychology

Chemical & Substance for Abstract: Elimination of methadone benefits in the Oregon Health Plan and its effects on patients. Information

Substance Name: Methadone

Registry Number: 76-99-3

Grant and Affiliation Information for Elimination of methadone benefits in the Oregon Health Plan and its effects on patients.

AFFILIATION: Department of public health and preventive medicine at Oregon Health and Science University, CB-669, Portland, Oregon 97239, USA. fullerb@ohsu.edu

Country: United States

AGENCY: United States NIDA

GRANT: R01-DA1-4688

ACRONYM: DA

MEDLINETA: Psychiatr Serv

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Elimination of methadone benefits in the Oregon Health Plan and its effects on patients Related Publications

• Aircrew maintenance; a problem of aviation preventive medicine.
• Auditory-visual interaction in the generation of saccades in man.
• Can visual function be restored in patients with homonymous hemianopia?
• Control of voluntary and reflexive saccades.
• Corpus callosum section in experimental epilepsy in the monkey.
• Does marital maladjustment lead to mental illness?
• Early and current factors associated with poor-quality marriage.
• Elimination of methadone benefits in the Oregon Health Plan and its effects on patients.
• Emergency patient transfers from rural hospitals: a regional study.
• Eye movements in visual search indicate impaired saliency processing in Parkinson's disease.
• Factors affecting the electroencephalogram in children and adolescents.
• How do the experiences of the early separated and the early bereaved differ and to what extent do such differences affect outcome?
• Increasing GPI-anchored protein harvest concentrations from suspension and porous microcarrier CHO cell cultures.
• Inheritance of electroencephalogram patterns in children with behavior disorders.
• Lipomeningomyelocystocele.
• Oculomotor deficits indicate the progression of Huntington's Disease.
• Responses to temporal visual stimuli in migraine: the critical flicker fusion test.
• Rudimentary meningocele presenting with a scalp hair tuft. Report of two cases.
• Slowly expanding abdominal plaque. Dermatofibrosarcoma protuberans (DFSP).
• Some properties of an unidentified growth factor present in fish products.
• Supplementary eye field contributions to the execution of saccades to remembered target locations.
• The effects of enhanced external counterpulsation on time- and frequency-domain measures of heart rate variability.
• The internal control of action and Parkinson's disease: a kinematic analysis of visually-guided and memory-guided prehension movements.
• The sacred encounter in outreach.
• The value of the electroencephalogram as an index of generalized cortical activity.
• Value of equivocal signs in neurologic diagnosis.
• Vesicular eruption on the scalp. Varicella-zoster virus with Torulopsis glabrata colonization.
• Vision, illusions, and reality.
• Visual object memory and memory-guided saccades rely on shared mental representations.
• Volition and eye movements.